Pays: Suisse
Langue: italien
Source: Swissmedic (Swiss Agency for Therapeutic Products)
clofaziminum
Novartis Pharma Schweiz AG
J04BA01
clofaziminum
Capsule
clofaziminum 100 mg, rapae oleum raffinatum, lecithinum, sojae oleum partim hydrogenatum 9.333 mg, sojae oleum hydrogenatum 2.333 mg, cera flava, propylenglycolum, E 321, acidum citricum, Kapselhülle: gelatina, glycerolum (85 per centum), E 172 (rubrum), E 172 (nigrum), E 215 550 µg, ethylvanillinum, propylis parahydroxybenzoas natricus 280 µg, 4-methoxyacetophenonum, aqua purificata, Drucktinte: lacca, E 171, propylenglycolum, pro capsula.
B
Synthetika
La lebbra
zugelassen
1969-04-24